BUFFALO, N.Y. – A New England Journal of Medicine (NEJM)
paper published today and co-authored by University at Buffalo
neurosurgeons reports that stroke patients have a much better
chance of surviving and returning to normal function when they
receive clot-busting drugs in conjunction with a wire mesh stent
device, than when they receive the medications alone.